Chronic obstructive pulmonary disease Trials in Hellerup, Denmark
Conditions / Chronic obstructive pulmonary disease / Hellerup, Denmark
Research into Chronic obstructive pulmonary disease spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00620022 | The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT00393458 | Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control | COMPLETED | PHASE3 |
| NCT01329029 | Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) | COMPLETED | PHASE4 |
| NCT00845728 | Exacerbation Study | COMPLETED | PHASE3 |
| NCT05037929 | A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 |
| NCT03660501 | Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease - an Observational Study | COMPLETED | — |
| NCT05351242 | Thermotherapy Against Persistent Bacterial LUNG Infections | RECRUITING | NA |
| NCT05878769 | A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) | RECRUITING | PHASE3 |
| NCT01120691 | Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations | COMPLETED | PHASE3 |
| NCT00206167 | A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD | COMPLETED | PHASE3 |